Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moran Kevin Patrick
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Chrousos Phaedra
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Honore Tage
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ward Anne Sempowski
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Mitchell Stephen Ray
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DUGAN RICHARD W
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Williams Timothy
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moran Kevin Patrick
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Polymeropoulos Mihael Hristos
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wijkstrom Joakim
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birznieks Gunther
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Polymeropoulos Mihael Hristos
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Moran Kevin Patrick
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wijkstrom Joakim
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Williams Timothy
Vanda Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Birznieks Gunther
Vanda Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.01%)
Vanda Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renaissance Technologies LLC 26-0385758(6.40 %),RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734(6.40 %)
Vanda Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dimensional Fund Advisors LP(3.4%)
Vanda Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(14.5%)
No Data
No Data